Brod, Meryl
Højbjerre, Lise
Pfeiffer, Kathryn M.
Sayner, Robyn
Meincke, Henrik H.
Patrick, Donald L.
Funding for this research was provided by:
Novo Nordisk A/S
Article History
Received: 6 June 2017
Accepted: 13 March 2018
First Online: 2 April 2018
Ethics approval and consent to participate
: Ethics approval was granted by Copernicus Institutional Review Board (CGIRB tracking #TBG1-15-642). Informed consent was obtained from all participants. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Not applicable.
: Drs. Brod, Pfeiffer, and Sayner are advisors/paid consultants to Novo Nordisk. Dr. Højbjerre and Mr. Meincke are employees of Novo Nordisk. Dr. Patrick is a paid consultant to Novo Nordisk.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.